Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Cancer Discov. 2013 Sep 3;3(11):10.1158/2159-8290.CD-13-0159. doi: 10.1158/2159-8290.CD-13-0159

Table 1. Univariate and multivariate analysis of overall survival and progression free survival results of 556 patients from TCGA dataset (a) and 91 OC patients from MDACC (b, c) - Data Portal (https://tcga-data.nci.nih.gov/tcga).

a. OS (n = 556)
Variable Univariate analysis Multivariate analysis
HR (95%CI) P value HR (95%CI) P value
EphA2 Low vs. High 0.62 (0.48-0.8) 0.0002 0.78 (0.7-1.01) 0.0575
EphB2 Low vs. High 0.69 (0.53-0.9) 0.0051 0.93 (0.73-1.2) 0.5972
miR-520d-3p Low vs. High 1.29 (1.02-1.63) 0.03 1.32 (1.03-1.69) 0.0297
DICER1 Low vs. High 1.43 (1.11-1.82) 0.0032 0.94 (0.73-1.21) 0.6271
Cytoreduction
operation
(Residual
disease vs. no
residual
disease)
0.94 (0.62-1.43) 0.77 0.92 (0.6-1.41) 0.6935
b. OS (n = 91)
MiR-520d-3p Low vs. High 1.873 (1.026-3.420) 0.041 3.168 (1.654-
6.066)
0.0005
Recurrence Positive vs.
Negative
29.967(1.587-565.723) 0.023
Dicer_di Low vs. High 2.518(1.396-4.542) 0.002 2.551(1.306-4.984) 0.0061
Drosha_di Low vs. High 2.594(1.431-4.705) 0.002 2.471(1.220-5.003) 0.0119
c. PFS (n = 91)
MiR-520d-3p Low vs. High 2.183 (1.208-3.944) 0.01 2.871 (1.563-
5.275)
0.0006
Cytoreduction
operation
Suboptimal vs.
optimal
1.638 (0.864-3.102) 0.007
Node metastasis Positive vs.
Negative
2.458 (1.091-50658) 0.03
Dicer_di Low vs. High 2.396 (1.319-4.355) 0.004 3.224 (1.7444-
5.959)
0.00018
Drosha_di Low vs. High 2.244 (1.241-4.060) 0.008